These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 385023)

  • 1. A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
    Dawson A; Johnson BF; Smith IK; Munro-Faure AD
    Br J Clin Pharmacol; 1979 Aug; 8(2):149-54. PubMed ID: 385023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol and bendrofluazide: comparison of their antihypertensive effects.
    Horvath JS; Caterson RJ; Collett P; Duggin GG; Kelly DH; Tiller DJ
    Med J Aust; 1979 Jun; 1(13):626-8. PubMed ID: 386062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of hypertension with propranolol and bendrofluazide.
    Agrawal RL; Alliott RJ; George M; Gomez G; Trafford JA; Jequier PW; Lishman JD; Turner JR; Baber NS; Dawes PM
    J R Coll Gen Pract; 1979 Oct; 29(207):602-6. PubMed ID: 536969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension.
    Webster J; Dollery CT; Hensby CN
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():125s-128s. PubMed ID: 7004720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol and bendrofluazide.
    Robinson IG; Allen B
    Med J Aust; 1979 Oct; 2(7):366. PubMed ID: 514192
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol, a cross-over double blind controlled trial.
    Sanders GL; Routledge PA; Rao JG; Gales GM; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1978 Dec; 14(5):301-4. PubMed ID: 365543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
    Jäättelä A
    Ann Clin Res; 1979 Apr; 11(2):80-2. PubMed ID: 378094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol and bendrofluazide in hypertension.
    Petrie JC; Galloway DB; Webster J; Simpson WT; Lewis JA
    Br Med J; 1975 Oct; 4(5989):133-5. PubMed ID: 1104047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
    Salvetti A; Pedrinelli R; Sassano P; Arzilli F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension.
    Singer DR; Markandu ND; Sugden AL; MacGregor GA
    Eur J Clin Pharmacol; 1990; 39(3):227-32. PubMed ID: 2257857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency treatment of severe hypertension with intravenous labetalol.
    McGrath BP; Matthews PG; Walter NM; Maydom BW; Johnston CI
    Med J Aust; 1978 Oct; 2(9):410-1. PubMed ID: 732728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.